Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
164
天
Defining a Therapeutic Window for Venetoclax in Post‐Transplant Maintenance Therapy for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
作者
Cuicui Lyu; Tianle Xie; Yedi Pu; Xianshuang Luan; Xia Xiao; Mingfeng Zhao; Hairong Lyu展开收起
作者单位
1. Department of Hematology Tianjin First Central Hospital Tianjin Thrombosis and Hemostasis Institute Tianjin China; 2. Department of Oncology Xinzhou People's Hospital Xinzhou Shanxi China展开收起
314
天
DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis
作者
Santosh Kumar Gothwal; Kyoko Oichai; Hongtae Kim; Kyungjae Myung; Jacqueline H. Barlow展开收起
作者单位
1. Institute of Frontier Science Initiative Kanazawa University Kanazawa Japan; 2. Center for Genomic Integrity Institute for Basic Science Daejeon South Korea; 3. Department of Biochemistry Graduate School of Medicine Tohoku University Sendai Japan; 4. Department of Biological Sciences Ulsan National Institute of Science and Technology Ulsan Korea; 5. Department of Microbiology and Molecular Genetics University of California Davis Davis California USA展开收起
224
天
Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines
作者
Marina Pérez‐Aguilera; Lucía Pedrosa; Sagrario Gómez; Sara Salazar‐Ortego; Ismael Fernández‐Miranda; Rafael Muñoz‐Viana; Paloma Martín‐Acosta; Beatriz L. Martín‐Lunas; Rebeca Jimeno; Natalia Yanguas‐Casás; Beatriz Horcajo; Giovana Roncador; José A. Martínez‐Climent; Ana Ortega‐Molina; Margarita Sánchez‐Beato展开收起
作者单位
1. Medical Oncology Department Lymphoma Research Group Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 2. Immune System Development and Function Department Metabolism in Cancer and Aging Research Group Centro de Biologia Molecular Severo Ochoa (CBM), CSIC—Universidad Autonoma de Madrid Madrid Spain; 3. Bioinformatics Unit Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 4. Pathology Department Cancer Molecular Pathology Group Hospital Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 5. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain; 6. Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO) Madrid Spain; 7. Department of Haematology Center for Applied Medical Research Cancer Center Clinica Universidad de Navarra IDISNA CIBERONC Pamplona Spain展开收起
32
天
FLT3‐ITD Measurable Residual Disease in Acute Myeloid Leukemia: Recommended, but Not Yet Self‐Sufficient
作者
Francesco Albano展开收起
作者单位
1. Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‐J)‐Hematology and Stem Cell Transplantation Unit University of Bari “Aldo Moro” Bari Italy展开收起
67
天
Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis
作者
Yubiao Pan; Yue Wang; Yaqin Xiong; Panpan Li; Chenqi Yu; Peng Liu展开收起
作者单位
1. Department of Hematology Zhongshan Hospital Fudan University Shanghai China展开收起
268
天
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T‐Cell Lymphoma
作者
Hayder Saeed; Melanie Mediavilla Varela; Eva Sahakian; Mahrukh Naqvi; Qianxing Mo; Ling Zhang; Rikesh Makanji; Yumeng Zhang; Ning Dong; Leidy Isenalumhe; Sameh Gaballa; Julio Chavez; Bijal Shah; Celeste Bello; Lubomir Sokol; Javier Pinilla‐Ibarz展开收起
作者单位
1. Department of Malignant Hematology Moffitt Cancer Center Tampa Florida USA; 2. Department of Biostats and Bioinformatics Moffitt Cancer Center Tampa Florida USA; 3. Department of Pathology Moffitt Cancer Center Tampa Florida USA; 4. Department of Radiology Moffitt Cancer Center Tampa Florida USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天